Readmission rates and outcomes in adults with and without COVID-19 following inpatient chemotherapy admission: A nationwide analysis

Table 5 Independent predictors of 30 d readmission for inpatient chemotherapy, Nationwide Readmission Database, 2020

Variables	Hazard ratio	Confidence interval	P value
Age category
45-64 years	0.83	0.79-0.87	< 0.001
65 years and above	0.78	0.72-0.85	< 0.001
Discharge AMA	0.69	0.49-0.97	0.031
Payer type
Medicaid	1.04	0.97-1.12	0.299
Private insurance	1.02	0.99-1.09	0.564
Self pay	1.05	0.90-1.23	0.522
Median household income
25th-50th quantile	1.04	0.97-1.12	0.137
50th-75th quantile	1.04	0.96-1.09	0.103
> 75th quantile	1.03	0.90-1.09	0.263
COVID-19	0.91	0.68-1.22	0.543
Comorbidities
Congestive heart failure	0.92	0.85-1.00	0.059
Cardiac arrhythmias	0.96	0.91-1.01	0.147
Peripheral vascular disorders	1.09	1.00-1.19	0.048
Hypertension, uncomplicated	1.03	0.99-1.07	0.111
Paralysis	1.26	1.08-1.47	0.003
Chronic pulmonary disease	0.96	0.91-1.02	0.233
Diabetics, uncomplicated	0.94	0.89-1.00	0.058
Renal failure	0.89	0.82-0.96	0.004
Liver disease	0.9	0.82-0.98	0.023
HIV/AIDS	1.14	1.01-1.30	0.038
Lymphoma	1.23	1.17-1.28	< 0.001
Coagulopathy	0.91	0.86-0.97	0.002
Weight loss	0.97	0.92-1.04	0.457
Hypertension, complicated	1.05	0.96-1.15	0.28

AMA: Against medical advice; HIV/AIDS: Human immunodeficiency virus/acquired immuno-deficiency syndrome.